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 Notes & Additional 
Reading 
Summary and Key Points  
1. Development of cervical cancer can be tracked as it 
progresses from cervical intraepithelial neoplasia to cervical 
carcinoma in situ to invasive cervical cancer. 
 
2. Human papillomavirus infection is central to the development 
of all cervical cancers. 
 
3. Most cervical cancers are squamous cell carcinomas.  
4. Treatment of cervical cancer can involve surgery, radiation, 
and/or chemotherapy. 
 
5. Close cooperation between gynecologic oncologists and 
radiation oncologists is mandatory for successful treatment of 
these cancers. 
 
  
Introduction  
Cervical cancer is an invasive cancer of the uterine cervix. It spreads 
either by direct extension, growing to involve the uterus, vagina, 
parametria (tissue just lateral to the cervix and uterus) and/or the 
pelvic side walls or through the lymphatic and less often vascular 
system. 
 
  
Cervical cancer is the 3rd most common gynecologic malignancy and 
the 6th most common solid malignant neoplasm among women in the 
United States (US). In 2010, approximately 12,200 cases were 
diagnosed in the US with 4,210 deaths.1 However; worldwide, 
cervical cancer is the 2nd most common cause of all cancer related 
deaths in women. In 2002, ~500,000 new cases were diagnosed in 
developing countries and there were ~ 275,000 deaths observed, 
corresponding to a ~50% mortality rate. 
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Through careful study of the cervical epithelium next to invasive 
cancers, it became clear that changes within the cervical squamous 
epithelium precede the development of invasive cervical cancer. 
Recognition of these initial intraepithelial changes enabled 
researchers and clinicians to develop effective screening modalities 
aimed at early detection. Furthermore the concept of a step-wise 
development of a cancer provided important insights into basic 
carcinogenic mechanisms applicable not only to cervical cancer but 
certain other human cancers. It is for these reasons that this disease 
provides an excellent model to learn prevention, progression, 
epidemiology and possible eradication of cancer. 
 
  
This chapter provides an overview of cervical cancer. The etiology, 
pathology, staging, and principles of treatment will be reviewed. 
 
  
Screening and Pre-Invasive Disease  
The cervical cytology known as Pap smear is a first screening tool 
that detects cervical precancerous changes. Treatment of these 
changes prevents progression to invasive or advanced stage of the 
disease. The Pap smear was named after George Papanicolaou, 
who developed it in the 1940’s. It was widely implemented in 1950’s 
in the USA. It works by evaluating scrapings of cervical cells under a 
microscope. This microscopic evaluation allows the pathologist to 
categorize cells as either normal or with varying degrees of 
precancerous changes (Figure 1). 
 
 
 
Figure 1. The Pap test is designed to sample only cells at the surface of the 
epithelium. In this image, there are several normal mature squamous cells 
(pink or blue depending on the presence of particular keratins—a feature 
that has no importance for students at this level). An arrow points to a 
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“Koilocyte” diagnostic of HPV infection. The koilocyte has a collapse of its 
keratins peripherally, leaving an empty space around the nucleus. The 
nucleus also shows increased amounts of hematoxylin staining, reflecting 
increased DNA content due to unscheduled DNA synthesis from the HPV. 
University of Massachusetts Medical School, Department of Pathology. 
  
The word “precancerous” has acquired a large number of synonyms. 
In part the large number of similar terms reflects medical-legal 
pressure to avoid implying that precancerous changes inevitably    
progress to invasive cancer. Synonyms include “pre-invasive”, 
“dysplastic”, “cervical intraepithelial neoplasia” (a term used to define 
histologic features in biopsies), or “squamous intraepithelial lesion” (a 
term used to define the cellular-level features seen in Pap smears 
 
  
Cervical cancer was one of the first human cancers to illustrate the 
now generally accepted concept that there is a step-wise progression 
from normal cells, to dysplastic cells, and finally to invasive disease. 
Cervical intraepithelial neoplasia (CIN) refers to pre-invasive 
dysplasia of cervical epithelial cells. It is the antecedent of malignant 
disease. CIN is categorized primarily according to the extent to which 
squamous cells fail to mature as they migrate from the basal zone 
next to the basement membrane to the surface of epithelium. In CIN 
I, (also known as “mild dysplasia”) cells begin to “mature” within the 
lower third of the epithelium (Figure 2). 
 
 
 
Figure 2. Cervical biopsy showing normal ectocervical squamous epithelium 
on the left and CIN 1 (low grade squamous epithelial lesion, mild dysplasia) 
on the right. CIN 1 is distinguished from normal squamous epithelium on the 
basis of irregular halos around enlarged nuclei, especially toward the upper 
half of the epithelium. These halos are caused by collapse of the keratin 
intermediate filaments due to their disassembly by the E4 protein of HPV. 
Such cells are called “koilocytes”, and the disassembly of the keratin 
probably causes the infected epithelial cells to slough off more readily, 
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thereby spreading virus. 
Normal squamous epithelium, under the influence of physiologic amounts of 
estrogen, accumulates glycogen as cell mature upward away from the basal 
layer. Glycogen is extracted in tissue processing and therefore also appears 
as a white-colored area around the nucleus in the maturing squamous cells. 
Compared to CIN 1, the normal glycogenated clear zone around the nuclei 
is more regular, giving rise to a “basket-weave” pattern, whereas the HPV 
infected cells show a disordered basket weave pattern. 
In CIN 1, multiple rounds of unscheduled DNA synthesis induced by HPV 
E6 and E7 genes cause exponential production of viral genomes. The 
unscheduled DNA synthesis also causes the nuclei to acquire polyploid 
amounts of DNA (2, 4, 8 or more times normal), which is reflected in the 
nuclear enlargement and hyperchromasia. 
The epithelium in both sides of the figure has the same thickness (about 
400 microns in this 200X magnification image). CIN 1 shows a relatively thin 
zone of basal cells, not too different from the normal squamous mucosa. It 
is this basal zone, at the lowest level of the epithelium adjacent to the 
underlying stroma, where cell division takes place. University of 
Massachusetts Medical School Department of Pathology. 
  
In CIN II (also known as “moderate” dysplasia), cells begin to mature 
in the middle third of the epithelium (Figure 3). In CIN III (also known 
as “severe dysplasia” or “squamous cell carcinoma in situ”) cells do 
not mature until the upper third of the epithelium (Figure 4). In Pap 
testing, a “low-grade squamous intraepithelial lesion” is synonymous 
with CIN I, whereas a “high grade squamous intraepithelial lesion” is 
synonymous with CIN II or CIN III (Figure 5 & Figure 6). 
 
 
 
Figure 3. This is a different cervical biopsy stained for Ki67 antigen, an 
antigen expressed in cells that have retained replication competence. The 
location of Ki67 staining cells is indicated by the brown color. The surface of 
the epithelium is toward the top and arrowheads show the location of the 
basal layer of the epithelium. In this biopsy, there is CIN 2 on the left half of 
the image, and normal squamous epithelium on the right half. 
Note that there is an increase in the thickness of the zone in which 
replication competence is maintained in the CIN 2. In CIN 2, replication 
competence is maintained for about half of the thickness of the epithelium. 
University of Massachusetts Medical School Department of Pathology. 
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Figure 4. A cervical biopsy is shown with CIN III, also known as “severe 
dysplasia”. Short arrows point to the location of the basal aspect of the 
epithelium; the underlying stromal tissue has been ripped away artifactually. 
Note the lack of change of the appearance of the cells as they grow away 
from the basal zone: it is as if the cells retained basal-like features, or lost 
the ability to differentiate as they reach the surface. Note also the mitotic 
cell that is approximately 2/3 of the way from the basal area to the surface 
(long thin arrow). University of Massachusetts Medical School Department 
of Pathology. 
Figure 5. A Pap test cytology sample is shown with a high grade squamous 
intraepithelial lesion, corresponding to a cervical biopsy with CIN III. A 
diagnostic feature of high grade dysplasia is the cell to cell variation in total 
amount of hematoxylin, corresponding to a cell by cell variation in total DNA 
content. In other words, there is “genetic instability” characterized by 
frequent gains and losses of chromosomes at each cell division. As an 
internal control for normal DNA content, look at the normal squamous cells 
(the two cells with the most cytoplasm) and compare their DNA content to 
the cluster of dysplastic squamous cells toward the left. High grade 
dysplastic cells do not acquire much cytoplasm, so the “nuclear to 
cytoplasmic ratio” is much higher (about 1:1.5) compared to the normal 
squamous cell (with an N:C ratio of about 1:7). University of Massachusetts 
Medical School Department of Pathology. 
Figure 6. Which of these two cervical biopsies shows normal squamous 
mucosa, and which one shows CIN? University of Massachusetts Medical 
School Department of Pathology. 
Expert Answer 
. 
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By definition, carcinoma in situ is limited to the epithelium and 
invasive carcinoma only occurs when the cells achieve the ability to 
grow in the extracellular matrix deep to the basement membrane. 
The slow progress of this transformation from dysplastic to invasive 
disease leads to a long latency period. Estimates of the time from the 
earliest changes to invasive cancer range from several years to 
decades. 
 
  
The great majority of cervical lesions have the potential to regress 
spontaneously, probably through immune mechanisms, allowing 
abnormal epithelial cells to become replaced with normal epithelium. 
This occurs commonly in adolescents, often leading to regression of 
their cervical dysplasia. Up to 90% of adolescents with HPV infection 
will have regression of their disease in 3 years and up to 75% of 
adults will have regression in this same time period. As a result of the 
high rate of spontaneous regression and the long latency, current 
recommendations are to start screening women with Pap smears at 
age 21. 
 
  
Etiology and Risk Factors  
The human papilloma virus (HPV) is known to be the major etiologic 
factor in development of cervical dysplasia and cancer. And it was 
recognized to be caused by specific HPV types. HPV is a sexually 
transmitted infection. There are many different strains of this virus 
that can infect the cervix, but only about 15 strains are associated 
with risk of cancer. Testing directly for these “high risk” HPV types is 
playing an increasingly large role in screening for cervical cancer, 
with the potential to replace Pap testing within the decade. To date, 
the most common strains associated with cervical intraepithelial 
neoplasia and cancer are HPV 16 and 18 (Figure 1). 
 
  
HPV infection is extremely prevalent in our population. Greater than  
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50% of all women will acquire HPV at some time in their life. Most 
HPV infections are cleared spontaneously by the body’s immune 
system, and infection with the virus alone is not sufficient to cause 
the development of cervical cancer. In fact, it is when HPV infection 
persists over time due to local or generalized humoral milieu that the 
development of intraepithelial neoplasia or invasive cancer, takes 
place. Time from initial infection to the development of invasive 
cervical cancer is estimated to take an average of 15-30 years 
depending on HPV strain involved (Figure 7). 
  
  
Expert Answer 
 
Figure 7. Which one of the two images shows HPV infection? University of 
Massachusetts Medical School Department of Pathology. 
 
  
There are several other risk factors associated with the development 
of cervical cancer. These include, early onset of sexual activity, a 
history of sexually transmitted diseases, smoking, 
immunosuppression, low socioeconomic status, and diethylstilbestrol 
(DES) exposure in utero. For many of these, except prenatal DES 
exposure, the increased risk is likely to be directly related to the risk 
of acquiring HPV infections. DES is associated with a different 
histologic type of cervical cancer, beyond the scope of this chapter. 
 
  
In the United States, the incidence of cervical cancer is 50 percent 
higher in African American women compared to their Caucasian 
counterparts and 66 percent higher in Hispanics compared to non-
Hispanic women. 
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Pathology  
Most cervical cancers arise from the transformation zone of the 
cervix where the squamous and columnar cells join, often referred to 
as the squamo-columnar junction (Figure 8). 
 
  
 
 
Figure 8. The squamo-columnar junction of the cervix is the zone between 
the squamous epithelium and the endocervical epithelium. This is the area 
in which cervical cancers start. In this image, a CIN III lesion is pushing from 
the left toward the normal columnar endocervical cells. University of 
Massachusetts Medical School Department of Pathology. 
 
  
In the US about 70% of cervical cancers are squamous cell 
carcinomas, arising from the squamous epithelial lining. 
Adenocarcinoma (arising from the endocervical mucous-producing 
glandular epithelium) accounts for approximately 25% (Figure 9) and 
a mixed adenosquamous carcinoma in about 3-5 percent. Other 
more infrequent malignant histologies include neuroendocrine or 
small cell carcinomas, rhabdomyosarcomas, lymphomas, and 
cervical sarcomas. These latter four forms of cervical cancer have no 
apparent relation to HPV. 
 
 
 
Figure 9. An endocervical adenocarcinoma, associated with HPV infection, 
is present at the right. A normal endocervical gland is on the left. Compared 
to the normal endocervical glandular cells, the endocervical 
adenocarcinoma shows nuclei that show a subtle variation (typically 
increased) in total hematoxylin content, and the ability of the malignant 
endocervical cells to stratify and survive in spite of the absence of a 
connection to the basal lamina. These features (DNA content variation 
reflecting genetic instability and ability to survive without a basal lamina 
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connection) are common diagnostic features of adenocarcinomas arising in 
many different sites. University of Massachusetts Medical School 
Department of Pathology. 
  
In developing nations, the vast majority of cervical cancers 
diagnosed each year are squamous cell carcinomas, with 
adenocarcinomas occurring much less commonly. The relative under 
representation of endocervical adenocarcinoma in the United States 
is likely to be due to the difficulty in detecting endocervical glandular 
lesions in Pap tests compared to the relative ease of detecting 
squamous precursors, although this trend is changing, either due to 
better detection technique with Thin Prep Cytology or increasing 
incidence of endocervical adenocarcinoma. 
 
  
Symptoms and Signs  
Cervical neoplasia has no symptoms until it becomes invasive in 
which time abnormal vaginal discharge that is unresponsive to 
treatment, post coital bleeding, irregular and out of phase menstrual 
bleeding and in advanced stage pelvic pain occur. The signs of 
invasive cervical cancer include an irregular firm feeling of the cervix. 
A knobby feeling can sometimes be appreciated when using a 
spatula to sample the cervix for a pap test. The cervical ulceration is 
seen in some cases on cervical inspection (Figure 10). 
 
 
 
Figure 10. This hysterectomy was performed for treatment of invasive 
cervical cancer. The cervical cancer can be seen at the arrow to be a 
“friable” (easily torn and prone to bleed) mass that projects out of the cervix. 
Compare the smooth tan texture of the normal squamous epithelium at 
12:00 in this image to the pinkish mass with a slightly irregular surface of 
the cancer. This patient presented with post-coital bleeding as a symptom. 
The cancer showed mixed squamous and endocervical histologic 
features—an “adenosquamous carcinoma”. University of Massachusetts 
Medical School Department of Pathology. 
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Staging 
Staging of cervical cancers differs from other cancers of the 
gynecologic tract. The majority of gynecologic malignancies 
are staged surgically; however cervical cancer is clinically staged. 
Since the extent of local disease is critical to staging, a good pelvic 
exam is mandatory. A thorough examination of the external genitalia 
and internal vagina needs to be performed in order to look for lesions 
since multifocal disease is not uncommon. The cervix itself is 
evaluated and may appear grossly normal if there is only 
microinvasive disease. Visible cervical lesions may appear 
exophytic, endophytic, polypoid, papillary, ulcerative or necrotic 
(Figure 10 and Figure 11). A bimanual rectovaginal examination to 
assess uterine size, vaginal wall, the rectovaginal septum, the 
parametrium, the uterosacral ligaments and the pelvic sidewall 
should be performed. 
Figure 11. 41-year-old female patient with biopsy proven cervical cancer. A 
sagittal image from an MRI of the pelvis demonstrates an endophytic lesion 
involving the posterior aspect of the cervix, consistent with the biopsy 
proven cervical cancer. Note the preserved low signal intensity (dark color) 
of the normal anterior aspect of the cervix. University of Massachusetts 
Medical School, Department of Radiology, Abdominal Imaging Division, 
Department of Radiology. 
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Due to discrepancies between the clinical staging and findings at 
surgery, the revised FIGO staging system now recommends 
obtaining pelvic MRI when available to better stage locally advanced 
disease. MRI is able to define the local extent of the disease 
including parametrium and pelvic sidewall invasion, urinary bladder 
and rectal invasion (Figure 12). Chest radiograph, CT scan, and PET 
scan can be utilized to evaluate the distant disease spread including 
lymphadenopathy and distant organ metastasis2. CT scan has 
replaced the traditional intravenous pyelography (IVP) to evaluate 
hydronephrosis (Figure 13). 
 
  
 
 
Figure 12. 45-year-old female patient with biopsy proven cervical cancer. 
Axial (a) and Sagittal (b) images from an MRI of the pelvis demonstrate 
abnormal signal intensity involving the entire cervix (loss of the normal dark 
color), consistent with the patient’s cervical cancer. The cervical cancer is 
extending into the myometrium in the lower uterine segment and into the 
parametrium. There is also abnormal signal intensity involving the posterior 
wall of the urinary bladder which appears irregular, with loss of its normal 
dark signal intensity, consistent with bladder wall invasion. University of 
Massachusetts Medical School, Department of Radiology Abdominal 
Imaging Division 
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Figure 13. Same patient in Figure 6. Coronal image from a non-contrast CT 
scan of the abdomen and pelvis reveals the presence of bilateral 
hydronephrosis. Note also the presence of an enlarged left pelvic lymph 
node, most likely metastatic. University of Massachusetts Medical School, 
Department of Radiology, Abdominal Imaging Division 
 
  
Biopsies of gross lesions are done. Colposcopy with biopsy of 
abnormal areas may be done as indicated. Endocervical curettage 
and cold knife conization (CKC) are often performed to determine 
depth of invasion and presence of lymphovascular space invasion in 
early stage cervical cancers with a normal appearing cervix by 
inspection and pelvic examination only. A CKC involves an excision 
of the transformation zone in a cone-shaped specimen with the apex 
of the cone pointed toward the endocervical canal beyond the 
transformation zone. Loop excisional electrocautery (LEEP) is 
typically used to treat CIN II-III. Compared to a LEEP, the CKC (in 
which cautery is only used after the excision to stop bleeding), 
preserves the morphology of the tissue to allow an accurate 
evaluation of the extent of disease by pathologists. The extent of the 
primary tumor, evident in a CKC is part of the information defined by 
the term “stage”, and the stage of a cervical cancer then determines 
the necessity for additional treatment. Cystoscopy and proctoscopy 
can be done to evaluate for a higher stage tumor defined by invasion 
of tumor into the bladder or rectum, respectfully. 
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The current staging system used for cervical cancer is located in the 
NCI’s Cervical Cancer Treatment PDQ: Stages of Cervical Cancer. 
 
  
Principles of Treatment  
Pre-invasive disease is generally treated with expectant 
management (lower grades of dysplasia) or removal of precursor 
lesions by LEEP, CKC, ablation or cryotherapy. 
 
  
Most cervical cancers that have not spread beyond the cervix are 
potentially cured with current treatments. However, once these 
cancers have spread into distant sites, such as lungs, bone, or liver, 
they are incurable and treatment is largely palliative. 
 
  
In general, early stage cervical cancers are treated with surgery. 
More advanced stages of cervical cancer are generally treated with 
radiation and concurrent chemotherapy. 
 
  
Currently, stage IA1 (lesions with <3mm invasion) disease is treated 
with cervical conization. Hysterectomy may be performed at a later 
time, when child bearing is complete. Stage IA2 (lesions with >3mm 
invasion and <5mm invasion) and stages IB1, IB2 and IIA can be 
treated with either surgically – with radical hysterectomy and bilateral 
pelvic lymphadenectomy or with primary radiation therapy including 
both brachytherapy and teletherapy.3 Survival rates from both modes 
of treatment are similar. Decision for surgical or radiation therapy is 
usually made on an individual basis and takes into account the 
patient’s age, medical co-morbidities and functional status. 
 
  
Stage IB2 or higher cervical cancer is usually treated with external 
beam radiotherapy (teletherapy) and concurrent chemotherapy 
(generally cisplatin) as a radiosensitizer. This first part of the course 
treats potential microscopic disease or actual bulk disease in the 
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pelvis or pelvic side walls, and hopefully shrinks the central tumor, so 
that the brachytherapy, which follows, can be more effective, by 
improving the anatomic geometry of the implant. Brachytherapy (i.e., 
“short distance” or localized and not external beam) radiation therapy 
with intracavitary radium or cesium or interstitial cesium needles is 
used to treat central tumor sites. 
  
In young women of childbearing age with an early stage 1B-2 
cervical cancer, radical resection of the cervix and pelvic lymph node 
dissection with preservation of the uterine fundus for future 
pregnancy has been accepted as a method of treatment. 
 
  
Stage IVB cervical cancer has a poor prognosis and is generally 
treated with the ultimate goal of palliation. 
 
  
With the completion of definitive therapy, each patient is evaluated 
with physical examinations and pap smears. They are generally 
evaluated every 3 months for 1-2 years, every 6 months until the 5th 
year and yearly thereafter. 
 
  
Cervical Cancer Prevention  
HPV vaccination has been developed to prevent women from 
developing intraepithelial neoplasia and cancer. This vaccination is 
against HPV 16-18 strains and is indicated for girls ages 9-26. 
 
  
Conclusion  
Squamous cell carcinoma of the cervix is an important model for the 
development of invasive cancer from viral infection through 
preinvasive disease and for screening. Worldwide, it is the fourth 
most common cancer in women; in the United States, it is the twelfth, 
and the rate continues to decline. 
 
  
Development of cervical cancer can be tracked as it progresses from  
Cervical Cancer 
Anne Garrison, MD 
Andrew Fischer, MD 
Adib R. Karam, MD 
Antonella Leary, MD 
Richard S. Pieters, MD 
15 
Cancer Concepts: A Guidebook for the Non-Oncologist- Cervical Cancer 
03 March 2015 
cervical intraepithelial neoplasia to cervical carcinoma in situ to 
invasive cervical cancer and human papillomavirus infection is 
central to the development of cervical cancer. These three facts 
mean that the appearance of invasive cancer can be prevented with 
early intervention. 
Thought Questions 
1. Cervical cancer may be one of the most preventable cancers.
From your knowledge of its pathogenesis, think of a variety of
prevention strategies that could reduce the incidence of cervical
cancer.
Expert Answer 
2. Cervical cancer is far more common in developing countries than
in industrialized countries. Why might that be? What barriers
could there be to the implementation of the prevention strategies
you developed in response to question #1 that might be more
common in developing countries?
Expert Answer 
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3. Advanced cervical cancer tends to invade regional structures.
What symptoms and complications might a woman with locally
advanced cervical cancer experience?
: Expert Answer 
4. . 
Figure 14. These two images are from breast biopsies. Extrapolating 
from the diagnostic features of endocervical adenocarcinoma, which of 
the figures shows normal ductal epithelium and which figure shows 
ductal carcinoma? University of Massachusetts Medical School 
Department of Pathology. 
: Expert Answer 
Glossary 
Brachytherapy- Close radiotherapy, either intracavitary or interstial, 
with radioactive sources put in a body cavity (intracavitary) or within 
tissue (interstitial) 
Clinical staging- an estimate of how much cancer there is based on 
the physical exam and imaging tests before surgery 
Colposcopy- Examination of the cervix with a colposcope, a 
magnifying devise which projects light onto the cervix; for evaluation 
of abnormal pap smears, special stains are applied to the cervix to 
enhance contrast between normal and abnormal tissue. 
Endophytic- inclined to grow inward into tissues in fingerlike 
projections from a superficial site of origin 
Exophytic- inclined to grow outward beyond the surface epithelium 
from which it originates 
Rhabdomyosarcoma- malignant tumor made up of striated muscle 
fibers 
Surgical staging- relies on what is learned during surgery in order to 
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fully assess the extent of disease 
Teletherapy- Distance therapy, i.e. external beam therapy  
Tumor “Grade"- Refers to the pathologist’s impression of how 
aggressive the tumor will behave. Grading for most cancers takes 
into account the following three features: 1) How closely do the cells 
resemble the cell of origin of the tumor? The degree to which tumor 
cells resemble the structure of normal tissue is referred to as 
“differentiation”. Intuitively, one can imagine that a “poorly 
differentiated” tumor (in which cells have lost much of the genetic 
programming of their origin), has evolved more, and is more likely to 
be able to adapt to new environments. For breast cancer, the degree 
of differentiation is estimated based on how well the cells can still 
cooperate to form tubular structures. For extremely well-differentiated 
“tubular carcinomas” of the breast, the risk of metastasis is close to 
zero. 2) How genetically unstable are the tumor cells? This is 
estimated from how much variability or “pleomorphism” is shown by 
the cells. The importance of pleomorphism can be understood 
intuitively: A highly genetically unstable, pleomorphic tumor is more 
likely to be able to evolve and adapt to new environments. 3-How 
fast is the tumor growing? Obviously a faster growing tumor may 
show a faster clinical evolution. Growth rate can be estimated based 
on the percentage of tumor cells that are in mitosis. More quantitative 
methods for estimating the growth rate can be achieved by 
immunohistochemical staining for proliferation markers. For example 
Ki67 immunostaining will highlight cells in S, M and G2 of the cell 
cycle. Image analysis of Ki67 staining shows promise for achieving 
more precise proliferation quantification. For certain tumors, there 
are other features that are important for “grade”. These include the 
presence of necrosis (particularly important for grading tumors of 
mesenchymal origin—i.e., sarcomas) and nucleolar size (particularly 
important for grading renal cell carcinomas). 
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